Results 201 to 210 of about 3,123,368 (386)
The Bind and the Slack of Basel Iii Liquidity Regulations: Evidence from Indonesia
Zaäfri A. Husodo, Arisyi Raz
openalex +1 more source
A multi‐technique pump‐probe setup capable of performing both transient reflectivity and time‐resolved Raman spectroscopy after ultrafast excitation, provides a comprehensive understanding of ultrafast electronic and phononic processes. Distinct decay rates for the temperature, frequency, and linewidth of the phonon mode in germanium are observed ...
Grazia Raciti +10 more
wiley +1 more source
Reply to Pastore, E.P. Comment on "Korkmaz et al. A Deep Learning and Explainable AI-Based Approach for the Classification of Discomycetes Species. <i>Biology</i> 2025, <i>14</i>, 719". [PDF]
Korkmaz AF +5 more
europepmc +1 more source
Halorotetin B, a novel small‐molecule terpenoid identified from an edible marine ascidian, exhibits strong anti‐tumor activity both in vitro and in vivo through direct targeting UBE2C to induce tumor cell cycle arrest and then lead tumor cell senescence. As a newly discovered UBE2C inhibitor, Halorotetin B can serve as a novel potential cell senescence
Shanhao Han +6 more
wiley +1 more source
3D volumetric analysis of upper airway changes following orthognathic surgery. [PDF]
Seifert LB +7 more
europepmc +1 more source
ABSTRACT Organoid research offers valuable insights into human biology and disease, but reproducibility and scalability remain significant challenges, particularly for epithelial organoids. Here, we present an integrated microfluidic platform that addresses these limitations by enabling high‐throughput generation of uniform hydrogel microparticles ...
Barbora Lavickova +8 more
wiley +1 more source
Papillary Fibroelastoma of the Aortic Root Causing Intermittent Coronary Ostial Obstruction: The Diagnostic Power of 3D Transesophageal Echocardiography. [PDF]
Bečić T +2 more
europepmc +1 more source
This study developed a novel drug delivery platform that overcomes the blood‐brain barrier in glioblastoma. By fusing IGFBP7 with small extracellular vesicles, the platform specifically targets tumor vasculature. It effectively delivers temozolomide, suppressing tumor growth at low doses.
Lingling Liu +17 more
wiley +1 more source

